Results 111 to 120 of about 630,791 (206)

Identification and Quantification of a Pneumococcal Cell Wall Polysaccharide by Antibody-Enhanced Chromatography Assay

Vaccines
Multivalent pneumococcal vaccines have been developed successfully to combat invasive pneumococcal diseases (IPD) and reduce the associated healthcare burden.
James Z. Deng, Zhifeng Chen, James Small, Yue Yuan, Kara Cox, Aimin Tang, Jeanette Roman, Liming Guan, Katrina Feller, Frances Ansbro, Kalpit Vora   +10 more
doaj   +1 more source

Evaluating immune responses to pneumococcal vaccines. [PDF]

Asia Pac Allergy, 2023
Thong BY, Pawankar R, Park HS, Abdul Latiff AH.   +3 more
europepmc   +1 more source

Analysis of the effectiveness of joint or sequential vaccination with pneumococcal and influenza vaccines in patients with chronic obstructive pulmonary disease [PDF]

, 2019
Г. Л. Игнатова, В. Н. Антонов, Е. В. Блинова   +2 more
openalex   +1 more source

Comprehensive Strategies for Prevention and Management of Antimicrobial Resistance in Respiratory Infections

Respirology, Volume 30, Issue 11, Page 1022-1024, November 2025.
Takahiro Takazono, Hiroshi Mukae
wiley   +1 more source

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities [PDF]

, 2021
Yan Li, Huaqing Wang, Wesley Furnback, Bruce C. M. Wang, Shuiqing Zhu, Peng Dong   +5 more
openalex   +1 more source

1106Modeling of nasopharyngeal acquisition as a function of anti-capsular serum antibody concentrations and of ethnicity after vaccination with pneumococcal conjugate vaccines (PCVs) [PDF]

, 2014
Ron Dagan, Christine Juergens, James Trammel, Scott D. Patterson, David Greenberg, Noga Givon‐Lavi, Nurith Porat, William C. Gruber, Daniel A. Scott   +8 more
openalex   +1 more source

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6) [PDF]

Paul T. Scott, Miwa Haranaka, Jung‐Hyun Choi, Helen Stacey, Marc Dionne, David Greenberg, Carlos G. Grijalva, Walter A. Orenstein, Doreen Fernsler, Nancy Gallagher, T Zeng, Jianing Li, Heather Platt, Timothy J. Chapman, Karyn Davis, Marc Dionne, Peter Dzongowski, Ginette Girard, Guy Tellier, Richard Tytus, S. Jaffuel, Jean‐François Nicolas, Eytan Ben Ami, Daniele Bendayan, Yoseph Caraco, Michal Chowers, Mahmud Darawsha, Avivit Peer, Francesco Bruno Blasi, Antonella Castagna, Claudio Costantino, Domenico Martinelli, Miwa Haranaka, Makoto Yono, Jung‐Hyun Choi, Won Suk Choi, Dong‐Gun Lee, Jacob Lee, Hyejin Shi, Joon Young Song, Gustavo de Luíz Martinez, José María Echave-Sustaeta María-Tomé, Cristina Masuet‐Aumatell, Silvia Narejos Pérez, Anna Vilella Morató, Kuo‐Chin Huang, Yi-Ching Yang, David Butuk, Jose Francisco Cardona, Nizar Daboul, Thomas Fiel, Neil J. Fraser, George Hartley Freeman, S Geller, Charles Harper, William Johnston, Thomas Lenzmeier, Enrique Pelayo, Laura Porterfield, Kathryn R. Rigonan, Jeffrey B. Rosen, Helen L Stacey   +61 more
openalex   +1 more source

Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine [PDF]

, 2017
Joon Kee Lee, Song I Yang, Sun Hyoung Park, Ki Wook Yoon, Hyunju Lee, Eun Hwa Choi, Hoan Jong Lee   +6 more
openalex   +1 more source

Knowledge, attitudes, and beliefs of pharmacists regarding vaccinations against influenza and pneumococci – a systematic review

Human Vaccines & Immunotherapeutics
Pharmacists’ knowledge, attitudes, and beliefs regarding vaccination can significantly influence patients’ willingness to receive vaccinations. This study aims to assess the level of knowledge, attitudes, and beliefs of pharmacists toward influenza and ...
Michał Waszkiewicz, Katarzyna Wnuk, Jakub Świtalski, Anna Augustynowicz   +3 more
doaj   +1 more source

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland

, 2012
Patricia R. Blank, Thomas D. Szucs
openalex   +1 more source